Repotrectinib for ROS1-Positive NSCLC
Sotorasib
Dabrafenib + Trametinib
NCCN Recommendations on Lung Cancer Care During COVID-19
LUNGevity Foundation
NCCN Guidelines for Patients®
The American Lung Association